Company profile: Alcyone Therapeutics
1.1 - Company Overview
Company description
- Provider of precision CNS genetic therapies and delivery technologies, including Falcon Precision Delivery System for precise intra-CSF drug delivery; ThecaFlex DRx System, an implantable system for direct intrathecal CSF access designed for safer, long-term drug administration; ACTX-101 gene therapy for Rett syndrome using X-reactivation; and miREX to reactivate silenced healthy X chromosomes for X-linked dominant mutations.
Products and services
- MiREX: A platform-scale genetic therapy approach targeting X-linked dominant genetic mutations by reactivating silenced, healthy X chromosomes in affected cells
- ACTX-101: A disease-specific gene therapy for Rett syndrome utilizing X-reactivation to correct mutations without overexpressing genes in healthy cells
- Falcon Precision Delivery System: A precision-engineered platform that architects intra-CSF drug delivery, optimizing dosing efficiency and targeting for neurological conditions through precise cerebrospinal administration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alcyone Therapeutics
SafeOp Surgical
HQ: United States
Website
- Description: Provider of a neuromonitoring device to prevent nerve damage in all types of surgical procedures, founded in 2011 and headquartered in Hunt Valley, Maryland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SafeOp Surgical company profile →
Renovo Concepts
HQ: United States
Website
- Description: Provider of Mechanical Tissue Resuscitation (MTR™), a therapeutic modality using controlled vacuum to enhance microcirculation, improve cell survival, and reduce injury volume and secondary pathologies. Offerings include the Sub-atmospheric Pressure Pump™ (SaPP™) and a Gen 1 MTR™ brain application targeting traumatic brain injuries to decrease injury severity and improve recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renovo Concepts company profile →
Mindset Pharma
HQ: Canada
Website
- Description: Provider of drug discovery and development focused on creating optimized, patentable next-generation psilocybin-inspired medicines and novel psychedelic compounds to treat neurological and psychiatric disorders, developing serotonin 5-HT2A agonists for conditions such as treatment-resistant depression and PTSD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mindset Pharma company profile →
Neurelis
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies addressing unmet medical needs, including VALTOCO, a prescription nasal spray for short-term treatment of seizure clusters in patients aged 6 and older; and pipeline programs NRL-1004 for acute agitation using proprietary Intravail delivery technology, and NRL-1049 for cerebral cavernous malformations, potentially the first FDA-approved treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurelis company profile →
Ionix Pharmaceuticals
HQ: United Kingdom
Website
- Description: Provider of discovery and development of new analgesic medicines for the treatment of acute and chronic pain. Based in Cambridge, UK, Ionix Pharmaceuticals leverages proprietary drug targets and state-of-the-art chemistry to alleviate pain associated with trauma and operative procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ionix Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alcyone Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alcyone Therapeutics
2.2 - Growth funds investing in similar companies to Alcyone Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alcyone Therapeutics
4.2 - Public trading comparable groups for Alcyone Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →